日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH

肺动脉高压症状和影响(PAH-SYMPACT®)问卷的开发:一种新的肺动脉高压患者报告结局评估工具

McCollister, Deborah; Shaffer, Shannon; Badesch, David B; Filusch, Arthur; Hunsche, Elke; Schüler, René; Wiklund, Ingela; Peacock, Andrew

Highly efficient elimination of colorectal tumor-initiating cells by an EpCAM/CD3-bispecific antibody engaging human T cells

通过与人类 T 细胞结合的 EpCAM/CD3 双特异性抗体高效消除结直肠肿瘤起始细胞

Ines Herrmann, Patrick A Baeuerle, Matthias Friedrich, Alexander Murr, Susanne Filusch, Dominik Rüttinger, Mariam W Majdoub, Sherven Sharma, Peter Kufer, Tobias Raum, Markus Münz

Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension

内皮素受体拮抗剂与肺动脉高压患者的气道功能障碍

Droste, Annette S; Rohde, David; Voelkers, Mirko; Filusch, Arthur; Bruckner, Thomas; Borst, Mathias M; Katus, Hugo A; Meyer, F Joachim